U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07505446) titled 'Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients' on March 26.
Brief Summary: Multidrug-resistant (MDR) bacteria represent a major global health concern, particularly among immunocompromised populations such as cancer patients undergoing chemotherapy. These individuals are highly vulnerable to severe bacterial infections due to compromised immune defenses. Consequently, empirical antibiotic therapy in high-risk immunosuppressed patients frequently involves the use of combination regimens consisting of two or more antimicrobial agents in order to broaden antibacterial co...